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The role of the innate immunity in lung inﬂammation of cystic ﬁbrosis (CF) has
been well described but T lymphocytes might also be important. In particular,
T helper 17 (Th17) cells can recruit neutrophils to an inﬂammatory site through
production of IL-17, which induces chemokine release. IL-23 is an important
inducer of IL-17 production. Elevated protein levels of IL-17 and IL-23 were
found in bronchoalveolar lavage (BAL) ﬂuid and sputum of CF patients during
exacerbation (McAllister et al., J Immunol 2005;175:404). Our aim was to study
the role of Th17 cells in CF lung disease by measuring IL-17 and IL-23 mRNA in
sputum of stable CF patients and by comparing these levels with healthy controls.
Sputum induction was performed in 39 stable adult CF patients (age: 25.6±6.2
years; FEV1: 65.8±18.6% predicted) outside of exacerbation and 11 controls (age:
27.5±10.9 years). Neutrophil counts ranged from 91.6±8.3% in the CF group and
42±23.7% in the controls. RNA was isolated and quantitative real-time RT-PCR was
performed. mRNA levels were normalised to the house keeping gene 18s rRNA.
We found signiﬁcantly higher levels of IL-17 (p< 0.0001) and IL-23 (p< 0.0001)
in the CF group compared to controls. There was a correlation between IL-17
and IL-23 mRNA expression in the CF group (p< 0.0001) and to a lesser extent
in the controls (p = 0.0426). The elevated levels of IL-17 and IL-23 mRNA could
explain the persistent neutrophil inﬁltration present in sputum of stable CF patients.
The correlation between IL-17 and IL-23 mRNA supports the potential role of the
IL-23-IL-17 axis in the pathophysiology of CF lung disease.
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Aspergillus fumigatus (Af) pulmonary infections are common in cystic ﬁbrosis.
A crucial feature of the host defense is to recruit neutrophils into the airways to
eradicate the invader. It is established that the Toll-like receptors (TLR) 2 and 4
play a role in the recognition of Af. In the present study, we show that bronchial
epithelial cells (BEC) synthesize the neutrophil chemoattractant interleukin (IL)-8
in response to Af. Upon Af stimulation, NF-úB activates a short IL-8 promoter
(−133) containing a binding site for NF-úB, and fused to the luciferase (Luc)
reporter gene. We looked for the involvement of MyD88, a common adaptor for
TLR2 and 4. BEC expressing a dominant negative form of MyD88 did not activate
NF-úB upon Af challenge but paradoxically still synthesized IL-8. PI3 kinase, p38
MAPK, and ERK1/2 are also activated upon Af challenge, and the use of speciﬁc
inhibitors showed that they are involved in IL-8 synthesis. As PI3 kinase and p38
MAPK inhibitors did not prevent activation of the IL-8-luc reporter gene, we suggest
that these two kinases act downstream of NF-úB, e.g. histone modiﬁcations or
mRNA stabilization. By contrast, the ERK1/2 inhibitor suppressed the IL-8 reporter
activation but did not alter the NF-úB activity, suggesting that the ERK1/2 pathway
activates a nuclear factor other than NF-úB, and essential for IL-8 synthesis. It
is concluded that Af-induced IL-8 production by BEC is not triggered through
the classical TLR-MyD88 signaling pathway, but is dependent on other pathways
involving kinases such as PI3 kinase, p38 MAPK and ERK1/2.
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Background: Identifying markers of inﬂammation relevant to CF airway disease
are necessary to monitor disease progression and could help determine novel drug
therapies.
Objective: To deﬁne biomarkers of the activation state of neutrophils (PMNs)
collected from sputa and blood in the same CF patients, devoid of bacterial
contamination.
Methods: We compared PMNs collected from airway and blood of CF children
to blood PMNs from healthy subjects. We performed a macroarray analysis of
1050 genes coding for cytokines and their receptors, apoptosis-related and signaling
molecules.
Results:We demonstrate an upregulation of 62 genes and downregulated expression
of 27 genes in CF blood PMNs compared to healthy blood PMNs. Among
upregulated genes were vitronectin, chemokines, particularly CCL17 and CCL18,
interleukin (IL) receptors (IL-3, IL-8, IL-10, IL-12), all three colony stimulating
factors (G-, M-, GM-CSF) and genes involved in NF-úB/IúB-a signaling. The
upregulation of 6 genes in CF blood PMNs (thrombospondin-1, CXCL10, CCL17,
IKKe, IL-10Ra and G-CSF) was conﬁrmed by qPCR. High levels of G-GSF in CF
blood PMNs supernatants were observed. When comparison was performed between
blood and airway PMNs in CF child, there was a limited difference in terms of gene
expression. Only the mRNA expression of amphiregulin and tumor necrosis factor
(TNF) alpha receptor p55 were higher in airway PMNs. Signiﬁcant amounts of
amphiregulin were detected in CF sputa. Amphiregulin is an EGF receptor ligand
that mediates TNF-a induced IL-8 secretion in airway epithelial cells.
Conclusion: Our ﬁndings make amphiregulin a new biomarker of CF-associated
airway inﬂammation.
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Aims: Surfactant protein D (SP-D) is a defence lectin of the innate immune system
with implications for pulmonary inﬂammation and clearance of microbes. SP-D
interacts with Pseudomonas and promotes phagocytosis and killing of spores of
Aspergillus fumigatus in vitro. SP-D levels are decreased in bronchoalveolar lavage
from patients with cystic ﬁbrosis, and there is increased proteolytic degradation of
SP-D. It is not known if serum SP-D likewise might reﬂect disease activity and we
examined the serum SP-D as a marker for CF lung disease.
Methods: We measured serum SP-D at a routine visit on 111 CF patients (children
and adults). We measured the forced expiratory volume in 1 second (FEV-1) at
sampling date (2002–2004) and again in 2005.
Results: In adults (19 y-old), the ln(se SP-D) level and the FEV-1 were linearly
correlated (−0.64, p< 0.001). The correlation remained signiﬁcant in adults two
to three years after the serum sampling (−0.72, p< 0.001). The corresponding
correlations were weaker in children, (Pearson = −0.29, p = 0.057) and (−0.26,
p = 0.045) for the initial and the follow up measurement, respectively.
Conclusion: Our results suggest that serum SP-D may be a valuable marker of lung
disease in CF patients. The correlation to FEV-1 is clear in adults. In children it is
acknowledged that FEV-1 is a relatively poor marker of lung disease compared to
CT scans. Further studies are warranted to investigate if SP-D improves evaluation
of disease activity in children, when compared to FEV-1.
